De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients

<div>HLA antigens recognized by C3d and/or C1q positive DSAs in the 39<i> dn</i>DSA-positive patients. A total of 78<i> dn</i>DSAs were identified in the 39 kidney recipients. Of those, 44 bound C1q and 18 displayed binding ability for C3d.</div>

Journal of Immunology Research

fig1

Figure 1

Figure 1: De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients 

Figure 1 | De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients 